Detalhe da pesquisa
1.
Correction to: Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor.
Invest New Drugs
; 37(3): 591, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30903344
2.
Treatment status and safety of crizotinib in 2028 Japanese patients with ALK-positive NSCLC in clinical settings.
Jpn J Clin Oncol
; 49(7): 676-686, 2019 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31008509
3.
Efficacy and safety of sunitinib in Japanese patients with progressive, advanced/metastatic, well-differentiated, unresectable pancreatic neuroendocrine tumors: final analyses from a Phase II study.
Jpn J Clin Oncol
; 49(4): 354-360, 2019 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30834940
4.
Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients.
Int J Clin Oncol
; 24(3): 262-273, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30392115
5.
Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients.
Int J Clin Oncol
; 24(3): 274-287, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30515674
6.
Palbociclib in combination with letrozole as first-line treatment for advanced breast cancer: A Japanese phase II study.
Cancer Sci
; 109(3): 803-813, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29345736
7.
Phase I study of palbociclib, a cyclin-dependent kinase 4/6 inhibitor, in Japanese patients.
Cancer Sci
; 107(6): 755-63, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26991823
8.
Efficacy and safety of monotherapy by pegvisomant, a growth hormone receptor antagonist, in Japanese patients with acromegaly.
Endocr J
; 63(4): 337-47, 2016 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26796763
9.
Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer.
Invest New Drugs
; 32(2): 261-70, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23665950
10.
A randomized, double-blind, controlled study of exemestane versus anastrozole for the first-line treatment of postmenopausal Japanese women with hormone-receptor-positive advanced breast cancer.
Breast Cancer Res Treat
; 139(2): 441-51, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23715630
11.
Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor.
Invest New Drugs
; 31(5): 1265-74, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23269537
12.
First-line sunitinib plus FOLFIRI in Japanese patients with unresectable/metastatic colorectal cancer: a phase II study.
Cancer Sci
; 103(8): 1502-7, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22537162
13.
Analysis of subsequent therapy in Japanese patients with hormone receptorâpositive/human epidermal growth factor receptor 2ânegative advanced breast cancer who received palbociclib plus endocrine therapy in PALOMA-2 and -3.
Breast Cancer
; 28(2): 335-345, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33085032
14.
Palbociclib-letrozole as first-line treatment for advanced breast cancer: Updated results from a Japanese phase 2 study.
Cancer Med
; 9(14): 4929-4940, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32420697
15.
Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer.
Breast Cancer
; 26(5): 651, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31168692
16.
Neutropenia management with palbociclib in Japanese patients with advanced breast cancer.
Breast Cancer
; 26(5): 637-650, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31127500
17.
Crizotinib versus Chemotherapy in Asian Patients with ALK-Positive Advanced Non-small Cell Lung Cancer.
Cancer Res Treat
; 50(3): 691-700, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28701030
18.
How Should a Globalized CTD Be Created? An Introduction to the Japanese 3-Layer Approach.
Ther Innov Regul Sci
; 49(1): 175-180, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30222462
19.
Phase I study of sunitinib plus modified FOLFOX6 in Japanese patients with treatment-naive colorectal cancer.
Anticancer Res
; 32(3): 973-9, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22399619